RKLB Stock Slides 9% After Neutron Launch Delay to Late 2026

Rocket Lab Corporation (RKLB) stock shares plunged 9.5% on Friday, closing at $65.79 after the company disclosed its first Neutron rocket launch has been pushed to late 2026. The delay overshadowed what was otherwise a solid Q4 earnings beat, with revenue of $179.7M exceeding the $178.5M estimate and EPS of $(0.09) beating the $(0.10) consensus. Despite the pullback, the stock has surged 118% over the past year, and Cantor Fitzgerald just raised its price target from $72 to $85, maintaining an Overweight rating.

Key Drivers of the RKLB Stock Move

• Neutron Delay Catalyst: The primary selloff driver was confirmation that Rocket Lab’s highly anticipated Neutron rocket, which competes with SpaceX’s medium-lift vehicles, won’t launch until late 2026 rather than earlier in the year. This represents a critical milestone delay for the company’s long-term growth strategy.
• Bull Case: Q4 results demonstrated strong operational execution with a seventh consecutive earnings beat. The company issued robust Q1 guidance of $185M to $200M versus $185M consensus. Recent contract wins include a multi-launch deal with BlackSky and strategic acquisitions of optical and precision component manufacturers to support national security satellites. Bank of America maintains a Buy rating with a $120 price target, while Morgan Stanley upgraded to Buy at $105.
• Bear Case: The Neutron delay raises questions about execution timelines in an increasingly competitive space launch market. Keybanc downgraded the stock to Hold in mid-January, and heavy insider selling continues with CFO Adam Spice disposing of $103M in shares and multiple other executives selling in January. The stock also faces sector-wide headwinds, with space stocks broadly declining after AST SpaceMobile’s dilutive capital raise in mid-February.

The market’s reaction reflects investor concern that Neutron delays could impede Rocket Lab’s ability to capture market share in the medium-lift category, where competition from SpaceX and emerging players intensifies. However, the company’s Electron small-sat launch business remains robust, and recent Pentagon SHIELD vendor list inclusion positions it well for defense contracts.

Record Backlog & Expanding Space Systems Portfolio

Beyond the Neutron timeline, Rocket Lab delivered record Q4 revenue of $179.65M (up from $132.39M YoY) and full-year revenue of $601.8M, while losses remained broadly similar year over year. The company ended 2025 with a record $1.85B backlog, driven in part by an $816M Space Development Agency contract, reinforcing long-term revenue visibility despite near-term launch delays.

Strategically, Rocket Lab continues expanding its vertically integrated space systems platform. The company completed acquisitions to deepen its component manufacturing capabilities, introduced new silicon solar arrays aimed at future orbital data center applications, and extended its multi-launch partnership with BlackSky.

The key dynamic: while Neutron delays pressure sentiment short term, the growing backlog and expanding end-to-end space infrastructure offering strengthen Rocket Lab’s long-term investment narrative as a diversified space systems provider — not just a launch company.

RKLB Smart Money Activity

Insider selling has been substantial and concentrated in early 2026. CFO Adam Spice led with a $103.1M disposal of 1.37M shares on January 5, followed by COO Frank Klein’s $7.3M sale of 100K shares on January 2. Director Merline Saintil sold $9.4M across two transactions in mid-January, while Director Jon Olson disposed of $1.4M. The timing and magnitude of these sales, particularly the CFO’s eight-figure transaction just weeks before the Neutron delay announcement, may warrant scrutiny. No government (Congress) trading activity has been recorded for RKLB in 2026.

RKLB Unusual Options

Options flow reveals significant hedging and speculation around earnings and the Neutron timeline. On February 24, the December 2026 $145 calls saw over $6.1M in premium traded, with mixed bullish and bearish sentiment. The most aggressive bullish bet was a $2.4M purchase of January 2027 $65 puts (sold to open), suggesting confidence the stock stays above $65. Following earnings on February 26, activity intensified with $627K in March $70 puts bought at the ask (bearish), while April $70 calls attracted $211K in premium (bullish). On Friday’s selloff, traders purchased $152K in April $65 puts as downside protection with the stock trading around $66. Call volume heavily concentrated in $70 to $145 strikes through December 2026, indicating expectations for either substantial recovery or continued volatility.

RKLB Analyst Focus

• Top Upgrades: Morgan Stanley upgraded to Buy on January 16 with a $105 price target (up from $67). Bank of America maintained Buy on January 20 and raised its target from $60 to $120. Cantor Fitzgerald increased its target from $72 to $85 on February 27 following earnings.
• Top Downgrades: Keybanc downgraded to Hold on January 15 with no price target. Goldman Sachs maintained its Hold rating but raised its target modestly from $47 to $69 on January 20.
• Median Price Target: Based on recent analyst actions, the median target is approximately $85, implying 29% upside from current levels. The wide range ($69 to $120) reflects uncertainty around Neutron execution and sector volatility.

RKLB Seasonality

Based on data since November 2020 (average 5.25 samples per month), February is historically RKLB’s weakest month with only 17% positive periods and an average decline of 9.7%. March extends this weakness with just 20% positive periods and a 6.7% average drop. The pattern shifts dramatically in summer, with June (80% positive, +12.6% average), July (80% positive, +15.4%), and November (60% positive, +24.1%) standing out as the strongest months. Friday’s 9.5% decline aligns perfectly with February’s historical weakness, suggesting seasonal headwinds may compound the Neutron delay news through March.

RKLB Relative Performance

RKLB significantly outperformed its industrials sector peers through most of early 2026, hitting a relative strength peak of 96.3 percentile (outperforming 96% of sector peers) on December 26. However, the stock has weakened considerably since then, dropping to the 94.9 percentile as of February 26 and likely lower following Friday’s selloff. Despite the recent decline, RKLB still ranks in the top 5% of its sector on a quarterly basis, demonstrating resilience relative to broader industrials volatility. The February sector underperformance coincides with space stock weakness triggered by capital raise concerns and valuation compression across high-growth aerospace names.